How the Viral Inactivation Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theViral Inactivation Market from 2025 to 2034?
The viral inactivation market is predicted to expand due to increasing incidences of numerous infectious diseases. These diseases, which can be transferred from one person to another through contaminated food and drinks and via pathogens such as viruses, bacterias, fungi, and parasites, call for the usage of viral inactivation. This technique is prevalently used in human disease-control programs where physical and chemical disinfectants are employed to deactivate viruses, aiding in preventing the transmission of virulent viral infections. As a result, this boosts the growth of the inactivation market. For instance, the Centers for Disease Control and Prevention, an American public health agency, indicated in March 2024 that the tuberculosis case count had surged from 8,320 in 2022 to 9,615 in 2023, translating to an increase of 1,295 cases. Moreover, the incidence rate also rose from 2.5 per 100,000 persons in 2022 to 2.9 in 2023. For these reasons, the increasing occurrence of various infectious diseases is fuelling the growth of the viral inactivation market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp
#How Will the CAGR of the Viral Inactivation Market Influence Its Overall Growth by 2034?
In recent periods, there has been sturdy growth in the size of the viral inactivation market. The market, which is projected to escalate from $5.01 billion in 2024 to $5.48 billion in 2025, is set to experience a compound annual growth rate (CAGR) of 9.4%. Factors contributing to this growth during the historic period include the increase in global air traffic, advanced navigation capacities, expansion of commercial aviation, cost efficiencies achieved by airlines, enhanced flight safety, and decrease in pilot workload.
The market size of viral inactivation is projected to experience a swift expansion in the following years, with estimates reaching up to “$8.28 billion in 2029 and showing a compound annual growth rate (CAGR) of 10.9%. Several factors expected to stimulate this growth in the projected period include advancements in autonomous flight, innovatory aircraft designs, initiatives towards sustainable aviation, urban air mobility (uam), and a growing demand for aircraft. The integration of advanced avionics, incorporation of artificial intelligence, innovations in the human-machine interface (hmi), retrofitting of existing aircraft, and integration of the global navigation satellite system (gnss) stand out as key trends in the forecast period.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10401
How Are Market Trends and Innovations Revolutionizing theViral Inactivation Industry in Recent Times?
The viral inactivation market is witnessing the growth of a key trend – the adoption of technologically advanced procedures. To remain competitive, corporations involved in the viral inactivation market are integrating these innovative methods. For instance, in March 2022, WuXi AppTec’s wholly-owned subsidiary, WuXi Advanced Therapies, launched a Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology from China. This state-of-the-art technology aids in the endorsement of new treatments through simultaneous, in-house assay formulation, biosafety, viral clearance, product release, and testing. This method offers a unique and innovative way to manufacture adeno-associated virus (AAV) at Good Manufacturing Practices (GMP) grade without requiring transfection.
Which Key Market Players Are Shaping the Future and Growth of theViral Inactivation Market?
Major companies operating in the viral inactivation market include Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation And Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report
#thebusinessresearchcompany #marketresearch #marketintelligence
The viral inactivation market covered in this report is segmented –
1) By Product: Kits And Reagents, Systems, Services
2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods
3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users
Subsegments:
1) By Kits And Reagents: Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes
2) By Systems: Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems
3) By Services: Viral Testing Services, Validation Services, Consulting Services
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10401&type=smp
What Regions Are Dominating the Viral Inactivation Market Growth?
North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Viral Inactivation Maret 2025, By The Business Research Company:
Healthcare E-Commerce Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/healthcare-ecommerce-global-market-report
Healthcare Personal Protective Equipment Global Market Report 2024
Pharmacies and Healthcare Stores Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
